Tag: Irukandji Syndrome
Phebra to spearhead clinical trial for Irukandji Syndrome antidote
Australian pharmaceutical company Phebra in collaboration with distinguished experts from around North Queensland will be working on a new clinical trial to test the...
Featured Article
GridBeyond highlights role of technology in navigating energy market swings
Energy price volatility continues to pose challenges for manufacturers and other energy-intensive industries, particularly as electricity markets experience more frequent and unpredictable price swings.
